Metraipolis › archive › dc_08f6fa3490d4

Post-transplant BRAF/MEK inhibitor maintenance sustains complete remission in BRAF V600E-mutant histiocytic sarcoma — Europe PMC PMID:42957845

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42957845
DOI
10.1007/s00277-[numero omesso]-6
License (as archived)
solo-consultazione
Archived
2026-10-31T15:24:24.677Z
SHA-256 of the archived text
c3b14328a5f2195413b8c0efc694c3c7c7baa5af97c5961d28d3789b6b4d94af
Stable URL of this page
https://metraipolis.com/documento/dc_08f6fa3490d4

How to cite

Post-transplant BRAF/MEK inhibitor maintenance sustains complete remission in BRAF V600E-mutant histiocytic sarcoma — Europe PMC PMID:42957845 — Europe PMC (en), https://europepmc.org/article/MED/42957845 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_08f6fa3490d4 (Metraipolis archive dc_08f6fa3490d4, sha256 c3b14328a5f2195413b8c0efc694c3c7c7baa5af97c5961d28d3789b6b4d94af)
BibTeX
@misc{dc08f6fa3490d4,
  title = {Post-transplant BRAF/MEK inhibitor maintenance sustains complete remission in BRAF V600E-mutant histiocytic sarcoma — Europe PMC PMID:42957845},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42957845},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_08f6fa3490d4; sha256 c3b14328a5f2195413b8c0efc694c3c7c7baa5af97c5961d28d3789b6b4d94af},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42957845. Agents can read the archived copy with the MCP tool read_document.